EE107 Long-Term Cost-Effectiveness of iGlarLixi Versus IDegLira in Patients With Uncontrolled Type 2 Diabetes Treated With Basal Insulin or Oral Antidiabetic Drug in China
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.406
https://www.valueinhealthjournal.com/article/S1098-3015(24)00521-7/fulltext
Title :
EE107 Long-Term Cost-Effectiveness of iGlarLixi Versus IDegLira in Patients With Uncontrolled Type 2 Diabetes Treated With Basal Insulin or Oral Antidiabetic Drug in China
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00521-7&doi=10.1016/j.jval.2024.03.406
First page :
Section Title :
Open access? :
No
Section Order :
11752